Instar Research

Instar is extremely pleased to announce that Dana Al-Juburi is joining the Instar EMEA team as an Associate Consultant. Over the course of her career, Dana has demonstrated exceptional growth and adaptability, swiftly ascending through the ranks in her previous role in research . Her rapid advancement is a testament to her sharp analytical skills and dedication to excellence. We are looking forward to Dana bringing her wide-ranging expertise to our consulting team, which will undoubtedly play a crucial role in supporting Instar's continued growth and success in the EMEA region. In response to her new position, Dana had the following to share: I'm thrilled to be taking this next step in my career, moving from Research to a Consultant role. I'm excited to bring my expertise to the table and contribute to the continued success of the Instar team! Please join us in welcoming Dana to the Instar team, we are very much looking forward to working with her! #instar

With just two days to go before the UEG Congress 2024 in Vienna, Instar is looking forward to what promises to be an exciting few days. #instar #instarresearch #UEG #UEGCongress2024

Given the underutilisation of biosimilars in selected Asian markets, Pfizer commissioned Instar to conduct market research to better understand physicians’ beliefs and perceptions of biosimilars in countries representing advanced/high income or emerging and developing/upper and lower middle-income economies. The approach leveraged Instar's proprietary ThinkTime tool to better understand how entrenched current beliefs are as well as Instar's Virtual Moderator, embedded into the survey to provide qualitative feedback with a quantitative sample. We are delighted to see that the findings of this research have been published this week in the peer reviewed journal, Expert Opinion on Biological Therapy.

Instar is extremely pleased to announce that Gemma McConnell is joining the Instar EMEA team as Research Director, Oncology Lead. Over the course of her career, Gemma has built upon a foundational oncology understanding. After completing  PhD in the field of cancer cell signalling, Gemma has focused on market research within the oncology space, bringing a wealth of oncology expertise across cancer types to the Instar team. In response to her new position, Gemma had the following to share: "I’m thrilled to have joined the Instar team! As the dynamic oncology market continually evolves, I look forward to supporting clients navigate this space” Please join us in welcoming Gemma to the Instar team, we are very much looking forward to working with her! #instar

It was great to have the whole Instar EMEA team come together two weeks ago in London for a very productive and fun Instar EMEA summit complete with choir practice - feeling energised and lucky to work with such a fantastic team (and talented singers)!

With just one day to go before the Intellus Institute 2024 in New Brunswick New Jersey, Instar is looking forward to what promises to be an exciting few days. Come and see us at our table to hear about some of Instar’s exciting innovations. We hope to see you there! #instar #instarresearch #Intellus2024 

With just over a week to go before the EphMRA 2024 Switzerland One Day Meeting in Basel, Instar is looking forward to what promises to be an exciting few days. Come chat to us and hear about some of Instar’s exciting innovations. We hope to see you there! #instar #instarresearch #EphMRA2024 #EphMRA

The Instar EMEA team embarking on some tantalising Japanese cuisine, following an exhilarating 2 day Strategy Workshop where, amongst other things, we discussed performance to date and future plans with innovation-led approaches and collaboration opportunities. Here's to a great Q3 and Q4!

We're thrilled to introduce our most advanced chatbot yet, designed to deliver superior insights beyond traditional open-ends. With generative AI, our chatbot provides deeper, more detailed insights that help our clients make better-informed decisions.

Instar is extremely pleased to announce that Cindy Adams is joining the Instar North America team as a Research Director. Cynthia Adams is joining Instar, bringing with her extensive experience in custom global market research. She has over 20 years of experience utilizing quantitative and qualitative methodologies, with a concentration in medical devices and the broader healthcare sector. Her experience spans many therapy areas, collaborating with clients to address a cross section of business issues, including brand and customer strategies, market opportunity, new product development, pricing, and advertising effectiveness. Please join us in welcoming Cindy to the team. We are very much looking forward to working with her and excited to see what her expertise brings to our team! #instar